Health & Environmental Research Online (HERO)


Print Feedback Export to File
1997743 
Journal Article 
Letter 
Aluminum contamination of dialysis and intravenous fluids after asbestos-free depth filtration 
Vyth, A; Stolk, LM; Abbad, FC 
1986 
Yes 
American Journal of Hospital Pharmacy
ISSN: 0002-9289 
IPA/87/716018 
43 
10 
2390 
English 
IPA COPYRIGHT: ASHP The case of a pediatric continuous ambulatory peritoneal dialysis (CAPD) patient who developed high blood levels of aluminum (I) was briefly reported. It was found that dialysis fluid prepared by the hospital contained high concentration of I. Tests were conducted of the filters used to prepare the dialysis fluids and intravenous solutions. When CAPD solution was filtered through filters rinsed with sterile water, the concentrations of I in the solution after 40, 90, and 140 liters were filtered were 1140, 1110, and 700 mcg/l, respectively. Before filtration, the concentration of I in this solution was only 3 mcg/l. In other batches of CAPD solution, I concentrations of up to 7000 mcg/l were found. Some intravenous fluids prepared for patients in the neonatal ward also contained high concentrations of I, especially those fluids that also contained calcium gluconate. It was concluded that the factors that may contribute to increased washout of I from the filter material include high pH and osmolarity of the IV fluid, presence of divalent cations in the fluid, and a relatively slow filtration rate (in the case of small batches). 
Asbestos; 1332-21-4; Aluminum; CPD4NFA903; Index Medicus; Filtration; Dialysis; Infusions, Intravenous; Aluminum -- analysis; Drug Contamination 
OPPT
• Gluconates
     Literature Search
          Human Health
               Toxline (private)
          Environmental Hazard
               Toxline (private)
OPPT REs
• OPPT_Asbestos, Part I: Chrysotile_F. Human Health
     Total – title/abstract screening
          Off topic
• OPPT_Asbestos, Part I: Chrysotile_Supplemental Search
     LitSearch: Sept 2020 (Undated)
          ProQuest
          PubMed
          Toxline
          WoS
     Legacy Uses
          Health Outcomes